SI-BONE, Inc. (NASDAQ:SIBN) Insider Sells $49,606.20 in Stock

SI-BONE, Inc. (NASDAQ:SIBN) insider Anthony J. Recupero sold 3,937 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $12.60, for a total transaction of $49,606.20. Following the sale, the insider now directly owns 228,554 shares of the company’s stock, valued at approximately $2,879,780.40. The trade was a 1.69 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

SI-BONE Price Performance

SIBN traded down $0.17 during trading on Wednesday, hitting $12.15. 217,144 shares of the stock traded hands, compared to its average volume of 392,037. The company has a debt-to-equity ratio of 0.22, a current ratio of 8.25 and a quick ratio of 7.22. SI-BONE, Inc. has a twelve month low of $11.76 and a twelve month high of $21.70. The company has a market cap of $509.57 million, a price-to-earnings ratio of -13.39 and a beta of 1.22. The business has a 50 day moving average price of $13.91 and a 200 day moving average price of $14.26.

Hedge Funds Weigh In On SI-BONE

Several large investors have recently modified their holdings of SIBN. Harbor Capital Advisors Inc. boosted its stake in SI-BONE by 440.5% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 192,380 shares of the company’s stock valued at $2,487,000 after purchasing an additional 156,790 shares during the last quarter. Silvercrest Asset Management Group LLC boosted its stake in SI-BONE by 13.8% in the first quarter. Silvercrest Asset Management Group LLC now owns 1,060,937 shares of the company’s stock valued at $17,368,000 after acquiring an additional 128,702 shares during the last quarter. Vanguard Group Inc. grew its holdings in SI-BONE by 1.8% during the first quarter. Vanguard Group Inc. now owns 2,463,501 shares of the company’s stock valued at $40,328,000 after purchasing an additional 43,670 shares during the period. American Century Companies Inc. grew its stake in shares of SI-BONE by 22.8% during the 2nd quarter. American Century Companies Inc. now owns 1,986,476 shares of the company’s stock worth $25,685,000 after acquiring an additional 368,637 shares during the period. Finally, Divisadero Street Capital Management LP purchased a new position in shares of SI-BONE in the second quarter worth about $1,552,000. Institutional investors own 98.11% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on SIBN shares. Needham & Company LLC reissued a “buy” rating and set a $19.00 price objective on shares of SI-BONE in a report on Wednesday. Morgan Stanley cut their price objective on SI-BONE from $21.00 to $19.00 and set an “overweight” rating on the stock in a report on Tuesday, August 6th. Finally, Truist Financial lifted their target price on SI-BONE from $16.00 to $18.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Six investment analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $23.00.

SI-BONE Company Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.